DE60333226D1 - Atropisomere von 3-substituierten 4-arylchinolin-2-one-derivaten - Google Patents
Atropisomere von 3-substituierten 4-arylchinolin-2-one-derivatenInfo
- Publication number
- DE60333226D1 DE60333226D1 DE60333226T DE60333226T DE60333226D1 DE 60333226 D1 DE60333226 D1 DE 60333226D1 DE 60333226 T DE60333226 T DE 60333226T DE 60333226 T DE60333226 T DE 60333226T DE 60333226 D1 DE60333226 D1 DE 60333226D1
- Authority
- DE
- Germany
- Prior art keywords
- sup
- atropisomers
- derivatives
- substituted
- arylchinolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 108091006146 Channels Proteins 0.000 abstract 1
- 102000004257 Potassium Channel Human genes 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 108020001213 potassium channel Proteins 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43616002P | 2002-12-23 | 2002-12-23 | |
| PCT/US2003/041548 WO2004058260A1 (en) | 2002-12-23 | 2003-12-18 | Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60333226D1 true DE60333226D1 (de) | 2010-08-12 |
Family
ID=32682352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60333226T Expired - Lifetime DE60333226D1 (de) | 2002-12-23 | 2003-12-18 | Atropisomere von 3-substituierten 4-arylchinolin-2-one-derivaten |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6939968B2 (de) |
| EP (1) | EP1575589B1 (de) |
| JP (1) | JP2006512378A (de) |
| KR (1) | KR20050102081A (de) |
| CN (1) | CN1750821A (de) |
| AT (1) | ATE472328T1 (de) |
| AU (1) | AU2003300425A1 (de) |
| BR (1) | BR0317679A (de) |
| CZ (1) | CZ2005407A3 (de) |
| DE (1) | DE60333226D1 (de) |
| IL (1) | IL169294A (de) |
| MX (1) | MXPA05006814A (de) |
| NO (1) | NO20053078L (de) |
| NZ (1) | NZ541237A (de) |
| PL (1) | PL377492A1 (de) |
| RU (1) | RU2352563C2 (de) |
| TR (1) | TR200502440T2 (de) |
| WO (1) | WO2004058260A1 (de) |
| ZA (1) | ZA200505077B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2133330E (pt) | 2007-04-09 | 2014-03-31 | Daiichi Sankyo Co Ltd | Atropisómero de derivado de pirrole |
| US8680116B2 (en) | 2009-07-22 | 2014-03-25 | Merck Sharp & Dohme Corp. | Quinolinone PDE2 inhibitors |
| CA2908879C (en) * | 2013-04-10 | 2018-05-15 | Daiichi Sankyo Company, Limited | Crystal of pyrrole derivative and method for producing the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW504504B (en) | 1996-11-26 | 2002-10-01 | Bristol Myers Squibb Co | 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| NZ336628A (en) * | 1997-02-28 | 2001-03-30 | Pfizer Prod Inc | Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as AMPA-receptor antagonists |
| BR9915744A (pt) * | 1998-12-04 | 2001-08-21 | Bristol Myers Squibb Co | Derivados 4-arilquinolin-2-ona 3-substituìdos como moduladores do canal de potássio |
| TW562799B (en) * | 1999-12-01 | 2003-11-21 | Bristol Myers Squibb Co | Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| CA2431904A1 (en) * | 2000-12-20 | 2002-08-01 | Merck & Co., Inc. | (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
-
2003
- 2003-12-17 US US10/739,449 patent/US6939968B2/en not_active Expired - Fee Related
- 2003-12-18 DE DE60333226T patent/DE60333226D1/de not_active Expired - Lifetime
- 2003-12-18 RU RU2005123046/04A patent/RU2352563C2/ru not_active IP Right Cessation
- 2003-12-18 TR TR2005/02440T patent/TR200502440T2/xx unknown
- 2003-12-18 KR KR1020057011916A patent/KR20050102081A/ko not_active Application Discontinuation
- 2003-12-18 PL PL377492A patent/PL377492A1/pl not_active Application Discontinuation
- 2003-12-18 CN CNA2003801098331A patent/CN1750821A/zh active Pending
- 2003-12-18 AT AT03814399T patent/ATE472328T1/de not_active IP Right Cessation
- 2003-12-18 AU AU2003300425A patent/AU2003300425A1/en not_active Abandoned
- 2003-12-18 JP JP2004562595A patent/JP2006512378A/ja active Pending
- 2003-12-18 CZ CZ2005407A patent/CZ2005407A3/cs unknown
- 2003-12-18 NZ NZ541237A patent/NZ541237A/en unknown
- 2003-12-18 EP EP03814399A patent/EP1575589B1/de not_active Expired - Lifetime
- 2003-12-18 BR BR0317679-7A patent/BR0317679A/pt not_active IP Right Cessation
- 2003-12-18 WO PCT/US2003/041548 patent/WO2004058260A1/en active Application Filing
- 2003-12-18 MX MXPA05006814A patent/MXPA05006814A/es active IP Right Grant
-
2005
- 2005-06-20 IL IL169294A patent/IL169294A/en not_active IP Right Cessation
- 2005-06-22 ZA ZA200505077A patent/ZA200505077B/en unknown
- 2005-06-23 NO NO20053078A patent/NO20053078L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE472328T1 (de) | 2010-07-15 |
| JP2006512378A (ja) | 2006-04-13 |
| BR0317679A (pt) | 2005-11-29 |
| EP1575589A1 (de) | 2005-09-21 |
| IL169294A (en) | 2010-11-30 |
| US20040147749A1 (en) | 2004-07-29 |
| RU2005123046A (ru) | 2006-01-20 |
| NO20053078D0 (no) | 2005-06-23 |
| TR200502440T2 (tr) | 2005-10-21 |
| EP1575589A4 (de) | 2008-05-21 |
| US6939968B2 (en) | 2005-09-06 |
| ZA200505077B (en) | 2006-09-27 |
| NO20053078L (no) | 2005-08-29 |
| CN1750821A (zh) | 2006-03-22 |
| NZ541237A (en) | 2008-09-26 |
| WO2004058260A1 (en) | 2004-07-15 |
| CZ2005407A3 (cs) | 2005-10-12 |
| KR20050102081A (ko) | 2005-10-25 |
| AU2003300425A1 (en) | 2004-07-22 |
| RU2352563C2 (ru) | 2009-04-20 |
| EP1575589B1 (de) | 2010-06-30 |
| PL377492A1 (pl) | 2006-02-06 |
| MXPA05006814A (es) | 2005-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
| MEP52408A (en) | Substituted pyrrolo-pyrazole derivatives as kinase inhibitors | |
| MX2007003546A (es) | Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa. | |
| GEP20084357B (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
| ATE384058T1 (de) | Thiazolderivate | |
| EA200500304A1 (ru) | Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний | |
| JO2282B1 (en) | Oxazole derivatives | |
| MA27040A1 (fr) | Nucleosides substitues en 4' | |
| SE0401971D0 (sv) | Piperidne derivatives | |
| BG106013A (en) | New compounds and compositions as protease inhibitors | |
| SG151254A1 (en) | Substituted morpholine and thiomorpholine derivatives | |
| HK1080470A1 (en) | Heterocyclic compounds | |
| MA28279A1 (fr) | Derives d'indole et utilisation de ceux-ci comme inhibiteurs de kinase, notamment des inhibiteurs de ikk2 | |
| NO20025590D0 (no) | Fenylglycin-derivater | |
| MXPA06000921A (es) | Derivados de benzamidazoles como inhibidores de mek. | |
| MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
| HK1080467A1 (en) | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders | |
| IL164509A0 (en) | Furyl compounds | |
| MX2007011698A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| MXPA05007115A (es) | Nuevos agonistas inversos del receptor cb 1. | |
| NO20052994L (no) | Nye fosforamidderivater. | |
| MXPA05009282A (es) | Derivados de anilina sustituidos. | |
| ATE259813T1 (de) | Triazolopyrimidinderivate | |
| NO20053078L (no) | Atropisomerer av 3-substituerte-4-arylkinolin-2-on-derivater. |